Rapport Therapeutics Inc
NASDAQ:RAPP
Rapport Therapeutics Inc
NASDAQ:RAPP
Price:
33.58
USD
6.03%
Market Closed
Market Cap:
$1.6B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Rapport Therapeutics Inc
NASDAQ:RAPP
|
US |
|
Caixabank SA
MAD:CABK
|
ES |
|
MBB SE
F:MBB
|
DE |
|
S
|
Star Petroleum Refining PCL
SET:SPRC
|
TH |
|
Halliburton Co
NYSE:HAL
|
US |
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
US |
|
Kingsoft Cloud Holdings Ltd
NASDAQ:KC
|
CN |
|
Capital Ltd
F:C8D
|
UK |
|
PRISMI SpA
MIL:PRM
|
IT |
|
T
|
Thales SA
SWB:CSF
|
FR |
|
Aura Energy Ltd
ASX:AEE
|
AU |
|
V
|
Vallourec SA
PAR:VK
|
FR |
|
Global Dominion Access SA
MAD:DOM
|
ES |
|
S
|
Suntech SA
WSE:SUN
|
PL |
Wall Street
Price Targets
RAPP Price Targets Summary
Rapport Therapeutics Inc
Rapport Therapeutics Inc
Wall Street analysts forecast RAPP stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for
RAPP
is 53.27 USD
with a low forecast of 40.4 USD and a high forecast of 84 USD.
Lowest
Price Target
40.4
USD
20% Upside
Average
Price Target
53.27
USD
59% Upside
Highest
Price Target
84
USD
150% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is RAPP's stock price target?
Price Target
53.27
USD
53.27
USD
According to Wall Street analysts, the average 1-year price target for
RAPP
is 53.27 USD
with a low forecast of 40.4 USD and a high forecast of 84 USD.
